Polymorphic paracetamol conjugation: phenotyping in a Hungarian population

Area of Science:

• Pharmacogenetics
• Drug Metabolism
• Biochemistry

Background:

• Paracetamol (acetaminophen) is a widely used analgesic and antipyretic.
• Its metabolism involves Phase II conjugation reactions, primarily glucuronidation and sulfation.
• Understanding the population distribution of these pathways is crucial for personalized medicine.

Purpose of the Study:

• To investigate the distribution of paracetamol glucuronide and sulphate conjugation pathways in a Hungarian population.
• To identify potential bimodality in these metabolic pathways.
• To assess the utility of urinary paracetamol metabolite ratios for determining conjugation capacity.

Main Methods:

• Analysis of urinary paracetamol and its conjugates (glucuronide and sulphate) in 53 adult Caucasian subjects.
• Statistical analysis to determine the distribution patterns of conjugation pathways.
• Calculation of metabolite-to-parent drug ratios.

Main Results:

• Excretion of paracetamol glucuronide and sulphate was not normally distributed in the study population.
• Bimodality was observed, with 15.1% of subjects identified as extensive glucuronidators and 24.5% as extensive sulphatators.
• Urinary paracetamol conjugate/paracetamol ratios showed potential as indicators of conjugation capacity.

Conclusions:

• Paracetamol conjugation pathways exhibit significant inter-individual variability within the studied population.
• The findings suggest distinct subpopulations with extensive glucuronidation and sulfation capacities.
• Monitoring urinary metabolite ratios could serve as a practical method for assessing human glucuronide and sulphate conjugation capacity.